NTI clinical trial results imminent!!, page-2

Nice refreshers on the revenue we are dealing with here assuming results are good. It's no surprise as we close in on April to see the SP inching up. Fair enough, no-one wanted their capital tied up for an extra 3 months. It was always going to be a dead period once the publication timeline became clear. That was a major surprise to all of us. But now we are closing in on the company making announcement, it's time to get set. Well done for your low entry price. You timed it to perfection. GLTA